Answer Summary

Members shared their experiences navigating methotrexate use during the coronavirus pandemic, with several receiving official shielding... Read more

Members shared their experiences navigating methotrexate use during the coronavirus pandemic, with several receiving official shielding letters in the UK advising self-isolation through mid-August, while others reported conflicting guidance from their doctors about whether to continue or stop their medication. Several members described difficult personal decisions, including one who stopped methotrexate for three weeks only to experience a severe seven-week flare, with their doctor ultimately advising that staying on medication was safer since flaring increases inflammation and infection risk. A recurring theme was the frustration over inconsistent information, the challenge of balancing work pressures with health risks, and the emotional toll of making these decisions without clear official guidance.